10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
Relay Therapeutics Inc. (RLAY)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Casdin Capital Eli Casdin | 3,668,574 | $115,670 | +9% | 2.87% |
| 2. | Driehaus Capital Richard Driehaus | 3,050,702 | $96,189 | +7% | 1.14% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,049,113 | $64,609 | -31% | 2.52% |
| 4. | Perceptive Advisors Joseph Edelman | 1,943,097 | $61,266 | -4% | 0.88% |
| 5. | EcoR1 Capital Oleg Nodelman | 1,385,276 | $43,678 | -70% | 1.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 25,000 | Officer, Director | 403,082 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 1,021,952 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 10,000 | Officer | 10,000 | 2020-07-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.40 | 22,500 | Officer | 15,284 | 2021-11-15 | Filing | |
| $35.42 | 6,500 | Officer | 25,284 | 2021-11-15 | Filing | |
| $34.15 | 30,000 | Officer | 45,619 | 2021-10-15 | Filing | |
| $36.87 | 293 | Officer | 15,284 | 2021-09-27 | Filing | |
| $36.87 | 646 | Officer | 75,619 | 2021-09-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 234,246 | $7,385,776 | 0% | |
| 2. | 27,904,963 | $879,843 | 2.72% | |
| 3. | 13,686,804 | $431,545 | 0.03% | |
| 4. | 5,352,612 | $168,768 | 0% | |
| 5. | 4,884,037 | $153,994 | 0% |
News See All
Is Relay Therapeutics, Inc. (RLAY) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is RLAY A Good Stock To Buy Now?
In this article we will analyze whether Relay Therapeutics, Inc.
Billionaire Hedge Funds
